Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (22.621)

11

A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD

enthalten in: Journal of attention disorders | 2024

von Madaan, V. | Bhaskar, S. | Donnelly, G. | +1

12

A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Moreau, M. | Alouani, E. | Flecchia, C. | +24

13

Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis : A randomized controlled trial

enthalten in: Chinese medical journal | 2024

von Xiao, Y. | Qian, J. | Zhang, S. | +9

14

Gene Expression Signatures Predict First-Year Response to Somapacitan Treatment in Children With Growth Hormone Deficiency

enthalten in: The Journal of clinical endocrinology and metabolism | 2024

von Garner, T. | Clayton, P. | Højby, M. | +2

15

Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma : An Exploratory Analysis of AGO-OVAR11/ICON-7

enthalten in: Laboratory investigation; a journal of technical methods and pathology | 2024

von Heublein, S. | Pfisterer, J. | du Bois, A. | +18

16

Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Mikamo, H. | Takahashi, S. | Yamagishi, Y. | +17

17

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis : A randomized, double-blinded, vehicle-controlled, phase 3 trial

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Draelos, Z. | Stein Gold, L. | +18

18

Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Neurology | 2024

von Mercuri, E. | Vilchez, J. | Boespflug-Tanguy, O. | +25

ErratumIn: Lancet Neurol. 2024 Apr 18;:. - PMID 38643778

19

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

enthalten in: The New England journal of medicine | 2024

von Choueiri, T. | Tomczak, P. | Park, S. | +131

20

Deucravacitinib in plaque psoriasis : 2-year safety and efficacy results from the phase III POETYK trials

enthalten in: The British journal of dermatology | 2024

von Lebwohl, M. | Warren, R. | Sofen, H. | +12

CommentIn: Br J Dermatol. 2024 Feb 26;:. - PMID 38407434